Range Impact, Inc. Files 8-K with Material Agreement
Ticker: RNGE · Form: 8-K · Filed: Sep 24, 2025 · CIK: 1438943
| Field | Detail |
|---|---|
| Company | Range Impact, Inc. (RNGE) |
| Form Type | 8-K |
| Filed Date | Sep 24, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.15, $550,000, $100,000, $350,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-filing
TL;DR
RANGE filed an 8-K for a material agreement & equity sales. Keep an eye on this.
AI Summary
On September 23, 2025, Range Impact, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and other events. The filing was made on September 24, 2025.
Why It Matters
This 8-K filing indicates significant corporate activity, including a material definitive agreement and equity sales, which could impact the company's financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing mentions a material definitive agreement and unregistered sales of equity securities, which can introduce financial and operational risks.
Key Players & Entities
- RANGE IMPACT, INC. (company) — Registrant
- September 23, 2025 (date) — Date of earliest event reported
- September 24, 2025 (date) — Filing date
- Nevada (jurisdiction) — State of incorporation
- MALACHITE INNOVATIONS, INC. (company) — Former company name
- Vitality Biopharma, Inc. (company) — Former company name
- Stevia First Corp. (company) — Former company name
FAQ
What is the nature of the material definitive agreement entered into by Range Impact, Inc. on September 23, 2025?
The filing states that Range Impact, Inc. entered into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What were the details of the unregistered sales of equity securities mentioned in the filing?
The filing indicates unregistered sales of equity securities occurred, but the specific terms, amounts, or recipients of these sales are not detailed in the provided text.
What other events are reported in this 8-K filing besides the material agreement and equity sales?
The filing lists 'Other Events' and 'Financial Statements and Exhibits' as additional items, but the specific content of these sections is not detailed in the provided text.
When was Range Impact, Inc. incorporated, and in which state?
Range Impact, Inc. is incorporated in Nevada, as stated in the filing.
Has Range Impact, Inc. operated under different names previously?
Yes, Range Impact, Inc. was formerly known as MALACHITE INNOVATIONS, INC., Vitality Biopharma, Inc., and Stevia First Corp., with name change dates in 2021, 2016, and 2011 respectively.
Filing Stats: 1,151 words · 5 min read · ~4 pages · Grade level 10.7 · Accepted 2025-09-24 16:56:14
Key Financial Figures
- $0.15 — mmon stock (the "Shares") at a price of $0.15 per share. The aggregate gross proceeds
- $550,000 — he sale of the Shares are approximately $550,000. The Purchasers are Edward Feighan, the
- $100,000 — rs. Feighan and Cavanaugh each invested $100,000 in the Shares and Tower IV, LLC investe
- $350,000 — n the Shares and Tower IV, LLC invested $350,000. The Purchase Agreements contain the
Filing Documents
- form8-k.htm (8-K) — 54KB
- ex10-1.htm (EX-10.1) — 189KB
- ex10-2.htm (EX-10.2) — 181KB
- ex10-3.htm (EX-10.3) — 177KB
- ex99-1.htm (EX-99.1) — 10KB
- ex99-1_001.jpg (GRAPHIC) — 6KB
- 0001493152-25-014817.txt ( ) — 899KB
- rnge-20250923.xsd (EX-101.SCH) — 3KB
- rnge-20250923_lab.xml (EX-101.LAB) — 33KB
- rnge-20250923_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RANGE IMPACT, INC. Dated: September 24, 2025 By: /s/ Michael Cavanaugh Name: Michael Cavanaugh Title: Chief Executive Officer 3 EXHIBIT INDEX Exhibit No. Description 10.1 Securities Purchase Agreement, dated September 23, 2025, between the Company and Edward Feighan. 10.2 Securities Purchase Agreement, dated September 23, 2025, between the Company and Michael Cavanaugh. 10.3 Securities Purchase Agreement, dated September 23, 2025, between the Company and Tower IV, LLC. 99.1 Press Release from the Company dated September 24, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 4